Fibrocell Science Inc buy melinda
Start price
09.09.17
/
50%
€2.90
Target price
19.12.17
€3.97
Performance (%)
-78.57%
End price
19.12.17
€0.62
Summary
This prediction ended on 19.12.17 with a price of €0.62. The BUY prediction by melinda for Fibrocell Science Inc performed very badly with a performance of -78.57%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fibrocell Science Inc | - | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by melinda for this prediction
In the thread Fibrocell Science Inc diskutieren
zu folgen
Phase 1/2 Einleitung der Therapie am 23. Februar angekündigt, 2017. Phase 1 Daten für 3Q 2017
(Vom Mitglied beendet)
Stopped prediction by melinda for Fibrocell Science Inc
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.22
09.09.17
09.09.17
€4.40
19.12.17
19.12.17
-78.57%
19.12.17
19.12.17
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.08
26.06.17
26.06.17
€3.43
27.06.17
27.06.17
11.70%
27.06.17
27.06.17